JP2023513605A5 - - Google Patents
Info
- Publication number
- JP2023513605A5 JP2023513605A5 JP2022549103A JP2022549103A JP2023513605A5 JP 2023513605 A5 JP2023513605 A5 JP 2023513605A5 JP 2022549103 A JP2022549103 A JP 2022549103A JP 2022549103 A JP2022549103 A JP 2022549103A JP 2023513605 A5 JP2023513605 A5 JP 2023513605A5
- Authority
- JP
- Japan
- Prior art keywords
- peptide
- cells
- cell
- present
- dendritic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062976654P | 2020-02-14 | 2020-02-14 | |
| US62/976,654 | 2020-02-14 | ||
| PCT/US2021/017958 WO2021163562A2 (en) | 2020-02-14 | 2021-02-12 | Compositions and methods comprising splicing-derived antigens for treating cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023513605A JP2023513605A (ja) | 2023-03-31 |
| JP2023513605A5 true JP2023513605A5 (https=) | 2024-02-16 |
Family
ID=77295208
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022549103A Pending JP2023513605A (ja) | 2020-02-14 | 2021-02-12 | がんを処置するためのスプライシング由来抗原を含む組成物および方法 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US20240182518A1 (https=) |
| EP (1) | EP4103738A4 (https=) |
| JP (1) | JP2023513605A (https=) |
| CN (1) | CN115485395A (https=) |
| WO (1) | WO2021163562A2 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021092436A1 (en) * | 2019-11-08 | 2021-05-14 | The Regents Of The University Of California | Identification of splicing-derived antigens for treating cancer |
| WO2023192626A1 (en) * | 2022-04-01 | 2023-10-05 | The Regents Of The University Of California | Methods and compositions for treating gliomas |
| CN116178567B (zh) * | 2022-10-28 | 2025-01-28 | 四川大学华西医院 | 一种靶向TGFβRII的嵌合抗原受体及其用途 |
| WO2024215872A1 (en) * | 2023-04-11 | 2024-10-17 | The Regents Of The University Of California | Human t cell receptors targeting tumor-enhanced splicing epitopes on hla-a*02:01 for small cell carcinoma |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
| CA2448109A1 (en) * | 2001-05-25 | 2002-12-05 | Thomas Jefferson University | Alternative splice forms of proteins as basis for multiple therapeutic modalities |
| EP4012714A1 (en) * | 2010-03-23 | 2022-06-15 | Iogenetics, LLC. | Bioinformatic processes for determination of peptide binding |
| GB201602918D0 (en) * | 2016-02-19 | 2016-04-06 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers |
| US20180305776A1 (en) * | 2017-04-20 | 2018-10-25 | The Board Of Trustees Of The Leland Stanford Junior University | Myc-reporters, cells containing myc-reporters and methods of use thereof |
| WO2021092436A1 (en) * | 2019-11-08 | 2021-05-14 | The Regents Of The University Of California | Identification of splicing-derived antigens for treating cancer |
-
2021
- 2021-02-12 JP JP2022549103A patent/JP2023513605A/ja active Pending
- 2021-02-12 WO PCT/US2021/017958 patent/WO2021163562A2/en not_active Ceased
- 2021-02-12 US US17/760,479 patent/US20240182518A1/en active Pending
- 2021-02-12 CN CN202180028467.5A patent/CN115485395A/zh active Pending
- 2021-02-12 EP EP21754447.7A patent/EP4103738A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220204933A1 (en) | Methods of using il-21 for adoptive immunotherapy and identification of tumor antigens | |
| JP2023513605A5 (https=) | ||
| Schuler et al. | The use of dendritic cells in cancer immunotherapy | |
| Reeves et al. | Retroviral transduction of human dendritic cells with a tumor-associated antigen gene | |
| JP6230208B2 (ja) | 樹状細胞／腫瘍細胞融合物および抗ｃｄ３／ｃｄ２８を使用する抗腫瘍免疫の刺激 | |
| US12589151B2 (en) | T cell modification | |
| Itoh et al. | Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen | |
| JP2019080568A (ja) | 腫瘍抗原を直接認識するために組換えｔ細胞レセプターを使用するための組成物及び方法 | |
| JP2011504101A5 (https=) | ||
| KR20140054140A (ko) | 췌장암에 대한 수지상 세포(ｄｃ) - 백신 치료요법 | |
| Adams et al. | Rapid tumor vaccine using Toll-like receptor-activated ovarian cancer ascites monocytes | |
| Salgaller et al. | Generation of specific anti-melanoma reactivity by stimulation of human tumor-infiltrating lymphocytes with MAGE-1 synthetic peptide | |
| JP2018511320A (ja) | 治療およびエピトープマッピング用Ｔ細胞の感作および増殖のためのｉｎ ｖｉｔｒｏ人工リンパ節法 | |
| CA2977836A1 (en) | Compositions and methods of treating cancer | |
| JP6602377B2 (ja) | 樹状細胞の製造方法、これにより製造された樹状細胞及びその用途 | |
| JP2018510644A (ja) | 治療およびエピトープマッピング用Ｔ細胞の感作および増殖のためのｉｎ ｖｉｔｒｏ人工リンパ節 | |
| CA2476143A1 (en) | Method for inducing cytotoxic t lymphocyte | |
| AU2016243626A1 (en) | Compositions and methods of treating multiple myeloma | |
| JP2024516542A5 (https=) | ||
| JP2024517630A5 (https=) | ||
| JP2024526836A5 (https=) | ||
| RU2790867C1 (ru) | Способ активации цитотоксических Т-лимфоцитов в популяции мононуклеарных клеток крови при помощи мембранных везикул, полученных из генетически модифицированных опухолевых клеток меланомы М14 со сверхэкспрессией интерлейкина 2 | |
| Gnjatic | In vitro Stimulation of CD8 and CD4 T Cells by Dendritic Cells Loaded with a Complex of Cholesterol-Bearing Hydrophobized Pullulan and NY-ESO-1 Protein: Identification of a New HLA-DR15–Binding CD4 T-Cell Epitope | |
| CN114599378A (zh) | 用于肿瘤的治疗和/或预防的组合物 | |
| Maxwell | Dendritic cell mRNA delivery strategies for ovarian cancer immunotherapy |